← Back to Search

Behavioural Intervention

Coach-guided smartphone delivered CBT program for Psoriasis

N/A

Recruiting

Research Sponsored by Brigham and Women's Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Current depression symptoms, defined as a PHQ-9 score of 5 or greater

Dermatologist confirmed diagnosis of psoriasis

Timeline

Screening 3 weeks

Treatment Varies

Follow Up week 8

Awards & highlights

Study Summary

This trial is a small study where participants will be enrolled in an 8-week program using a smartphone app and will be guided by a coach. The program will last for 9 weeks, including a

Who is the study for?

This trial is for adults with psoriasis who also have symptoms of depression. Participants should be comfortable using a smartphone and willing to engage in an 8-week CBT program guided by a coach, followed by a follow-up interview.Check my eligibility

What is being tested?

The study is testing the effectiveness of an 8-week cognitive behavioral therapy (CBT) program delivered through a smartphone app, which includes guidance from a coach. All participants will receive this intervention.See study design

What are the potential side effects?

Since this is not a drug trial but rather involves psychological therapy via an app, typical medication side effects are not expected. However, some may experience discomfort or emotional distress when confronting personal issues during CBT.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am currently experiencing symptoms of depression.

Select...

A dermatologist has diagnosed me with psoriasis.

Select...

I currently have mild psoriasis symptoms.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ week 8

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~week 8

This trial's timeline: 3 weeks for screening, Varies for treatment, and week 8 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Client Satisfaction Questionnaire-8 (CSQ-8)

Participants Engagement

Patient Health Questionaire-9 (PHQ-9)

Secondary outcome measures

Appearance Anxiety Inventory (AAI)

Frequency of participants with adverse events

Psoriasis Symptom Inventory

+3 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Coach-guided smartphone delivered CBT programExperimental Treatment1 Intervention

All eligible participants will be enrolled in an 8-week coach-guided smartphone delivered CBT program. The full duration of the program, with follow-up interview, will be 9 weeks.

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Brigham and Women's HospitalLead Sponsor

1,615 Previous Clinical Trials

11,470,800 Total Patients Enrolled

4 Trials studying Psoriasis

1,138 Patients Enrolled for Psoriasis

National Psoriasis FoundationOTHER

11 Previous Clinical Trials

1,852 Total Patients Enrolled

10 Trials studying Psoriasis

1,830 Patients Enrolled for Psoriasis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the upper limit for participant enrolment in this research investigation?

"Indeed, the details found on clinicaltrials.gov indicate that this clinical trial is currently seeking participants. The trial was originally posted on January 1st, 2024 and underwent its most recent update on January 19th, 2024. This study aims to recruit a total of 30 individuals at one specified location."

Answered by AI

Is the recruitment of participants currently ongoing for this clinical trial?

"Indeed, according to the information available on clinicaltrials.gov, this research endeavor is actively seeking eligible participants. The study was originally posted on January 1st, 2024 and underwent its most recent update on January 19th, 2024."

Answered by AI

What are the main goals being pursued in this research endeavor?

"The main objective of this clinical trial is to assess the satisfaction level of participants using the Client Satisfaction Questionnaire-8 (CSQ-8) within an 8-week timeframe, starting from baseline. Secondary outcomes include participant dropout rate, measured as the number of individuals who do not complete the study, and Skindex-16 scores. The Skindex-16 measures functioning, emotions, and symptoms associated with chronic skin diseases on a linear scale ranging from 0 to 100. Additionally, Appearance Anxiety Inventory (AAI) will be used to evaluate cognitive processes and behavioral responses in Body Dysmorphic Disorder (BDD). AAI consists"

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Smart Phone Delivered Cognitive Behavioral Therapy for Adults With Psoriasis and Co-Morbid Depression Symptoms

Megan Noe, M.D 2024. "Smart Phone Delivered Cognitive Behavioral Therapy for Adults With Psoriasis and Co-Morbid Depression Symptoms". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06216691.

All > Depression Boston > Plaque Psoriasis